PharmEasy to acquire 66% stake in Thyrocare Tech for Rs 4,546 Cr

&NewLine;<p><strong>What is the news&quest;<&sol;strong><&sol;p>&NewLine;&NewLine;&NewLine;&NewLine;<p>PharmEasy&&num;8217&semi;s parent company API Holdings&nbsp&semi;has signed final paperwork acquiring a 66&period;1 percent ownership in the Thyrocare Technologies Pvt Ltd from Dr&period; A Velumani and affiliates&comma; for a price of Rs 1&comma;300 each share&comma; totaling Rs&period; 4&period;546 Cr&period; The acquisition is subject to regulatory and other customary approvals required&period;<&sol;p>&NewLine;&NewLine;&NewLine;&NewLine;<p><strong>Further information<&sol;strong><&sol;p>&NewLine;&NewLine;&NewLine;&NewLine;<p>&&num;8220&semi;We are thrilled to be collaborating with Thyrocare&comma;&&num;8221&semi; stated Siddharth Shah&comma; CEO of API Holdings&period; We deliver a world-class diagnostic customer experience&comma; rivaling our pharmaceutical experience with technological leverage and creating Thyrocare in a large-scale and truly pan-Indian presence&period; Our goal is to offer all ambulatory health goods and services within 24 hours to every Indian&period;&&num;8221&semi;<&sol;p>&NewLine;